{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:17:04Z","timestamp":1778537824004,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CF 23 2948 FK"],"award-info":[{"award-number":["CF 23 2948 FK"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN2021\/1469"],"award-info":[{"award-number":["CAN2021\/1469"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancer Society","doi-asserted-by":"publisher","award":["221212"],"award-info":[{"award-number":["221212"]}],"id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["909121#"],"award-info":[{"award-number":["909121#"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["FoUI-987045"],"award-info":[{"award-number":["FoUI-987045"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.lungcan.2025.108527","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T17:29:53Z","timestamp":1743614993000},"page":"108527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) \u2212 A subgroup analysis of the expanded HILUS study"],"prefix":"10.1016","volume":"203","author":[{"given":"Sara","family":"Lindberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitali","family":"Grozman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Onjukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Lindb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna \u00d6stling","family":"Palme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam Al","family":"Jirf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingmar","family":"Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wers\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte Fredberg","family":"Persson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Josipovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza Ahmed","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ditte Sloth","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Marquard","family":"Knap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninni","family":"Drugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rgen","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte Victoria","family":"Rogg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Traa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Knoph","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sofie","family":"Fr\u00f8land","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Ramberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan Starup","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine Bj\u00f8rn","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"L\u00f6d\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Olov","family":"Rosenbrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Engelholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"\u00c4nghede Haraldsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Billiet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Lewensohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.athoracsur.2011.09.079","article-title":"Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers","volume":"93","author":"Chen","year":"2012","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108527_b0010","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0360-3016(02)03986-X","article-title":"Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability","volume":"55","author":"Seppenwoolde","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0015","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine","year":"2016","journal-title":"Pract. Radiat. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108527_b0020","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u201cultracentral\u201d non-small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"30","key":"10.1016\/j.lungcan.2025.108527_b0025","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108527_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial - a prospective Nordic multi-center phase II study of ultra-central lung tumors treated with stereotactic body radiotherapy","author":"Lindberg","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108527_b0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jtcvs.2006.05.023","article-title":"Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma","volume":"132","author":"Ketchedjian","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.athoracsur.2007.03.081","article-title":"Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer","volume":"84","author":"Lee","year":"2007","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ejcts\/ezv489","article-title":"Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer","volume":"50","author":"Decaluwe","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100653","article-title":"Nodal recurrences after stereotactic body radiotherapy for early stage non-small-cell lung cancer","volume":"45","author":"Tibdewal","year":"2021","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.lungcan.2025.108527_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109697","article-title":"A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy","volume":"185","author":"Tonneau","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2025.108527_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.06.246","article-title":"Expanded HILUS trial: a pooled analysis of risk factors for toxicity from stereotactic body radiation therapy of central and ultracentral lung tumors","author":"Lindberg","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108527_b0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours","volume":"2","author":"Goldstraw","year":"2007","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The Eighth Edition Lung Cancer Stage Classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest."},{"key":"10.1016\/j.lungcan.2025.108527_b0075","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 2009."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0085","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaf26a","article-title":"The linear quadratic model: usage, interpretation and challenges","volume":"64","author":"McMahon","year":"2018","journal-title":"Phys. Med. Biol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108527_b0095","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.lungcan.2025.108527_b0100","unstructured":"RC T. [Available from: https:\/\/www.R-project.org\/ 2022]."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0300","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.annonc.2019.10.008","article-title":"Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials","volume":"31","author":"Magee","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2025.108527_b0305","article-title":"Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0310","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijrobp.2023.03.069","article-title":"Safety and efficacy results from iSABR, a phase 1 study of stereotactic ablative radiotherapy in combination with durvalumab for early-stage medically inoperable non-small cell lung cancer","volume":"117","author":"Wu","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2025.108527_b0315","unstructured":"Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients \/\u200b Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation (PACIFIC-4) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT03833154 [."},{"key":"10.1016\/j.lungcan.2025.108527_b0320","unstructured":"Efficacy and safety study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab (MK-3475) in adults with unresected stage I or II non-small cell lung cancer (NSCLC) (MK-3475-867\/KEYNOTE-867) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03924869."},{"key":"10.1016\/j.lungcan.2025.108527_b0325","unstructured":"A randomized phase III trial of induction\/consolidation atezolizumab (NSC #783608) plus SBRT versus SBRT alone in high risk, early stage NSCLC (SWOG 1914) https:\/\/www.swog.org\/clinical-trials\/s1914."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108527_b0330","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1556-0864(21)01905-5","article-title":"63MO Safety analysis of durvalumab following stereotactic body radiotherapy (SBRT) in early-stage non-small cell lung cancer (NSCLC) patients: A first report of a randomized phase II trial (ASTEROID)","volume":"16","author":"Aea","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"15","key":"10.1016\/j.lungcan.2025.108527_b0335","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108527_b0105","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","article-title":"Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer","volume":"6","author":"Haasbeek","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"23","key":"10.1016\/j.lungcan.2025.108527_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235908","article-title":"Survival and prognostic factors of ultra-central tumors treated with stereotactic body radiotherapy","volume":"14","author":"Salvestrini","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108527_b0115","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.21037\/tlcr-20-851","article-title":"Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer","volume":"9","author":"Sun","year":"2020","journal-title":"Transl Lung Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108527_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2023.100956","article-title":"Long-term outcomes in patients with central and ultracentral non-small cell lung cancer treated with stereotactic body radiotherapy: single-institution experience","volume":"47","author":"Song","year":"2023","journal-title":"Curr. Probl. Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2025.108527_b0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic radiation for ultra-central non-small cell lung cancer: a safety and efficacy trial (SUNSET)","volume":"120","author":"Giuliani","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108527_b0130","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"J. Am. Med. Assoc."},{"issue":"20","key":"10.1016\/j.lungcan.2025.108527_b0135","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2009.05.007","article-title":"Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial","volume":"68","author":"Ricardi","year":"2010","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","article-title":"SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC","volume":"121","author":"Nyman","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108527_b0150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/JTO.0b013e31827ce361","article-title":"Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer","volume":"8","author":"Robinson","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108527_b0160","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/cas.14185","article-title":"Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer","volume":"110","author":"Meng","year":"2019","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108527_b0165","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":"Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2025.108527_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"182","author":"Yan","year":"2023","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1533034615624045","article-title":"Limitations of PET\/CT in the detection of occult N1 metastasis in clinical stage I(T1-2aN0) non-small cell lung cancer for staging prior to stereotactic body radiotherapy","volume":"16","author":"Akthar","year":"2017","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.lungcan.2025.108527_b0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.lungcan.2017.04.018","article-title":"Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT","volume":"109","author":"Gao","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108527_b0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ctrv.2017.04.001","article-title":"Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors","volume":"56","author":"Wink","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108527_b0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN Clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1753465813512545","article-title":"Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation","volume":"8","author":"Haidar","year":"2014","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.lungcan.2025.108527_b0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2017.07.005","article-title":"Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"117","author":"Schonewolf","year":"2018","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108527_b0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/17476348.2022.2056023","article-title":"Complications and safety analysis of diagnostic bronchoscopy in COPD: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2022","journal-title":"Expert Rev. Respir. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108527_b0210","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0003-4975(99)00788-2","article-title":"PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma","volume":"68","author":"Kernstine","year":"1999","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2011.10.016","article-title":"Mediastinal lymph nodes staging by 18F-FDG PET\/CT for early stage non-small cell lung cancer: a multicenter study","volume":"102","author":"Li","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"5 Suppl","key":"10.1016\/j.lungcan.2025.108527_b0220","doi-asserted-by":"crossref","first-page":"e211S","DOI":"10.1378\/chest.12-2355","article-title":"Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Silvestri","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0225","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1002\/ijc.27779","article-title":"Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography\/computed tomography for the detection of metastases in non-small-cell lung cancer patients","volume":"132","author":"Wu","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40644-016-0091-3","article-title":"How We Read Oncologic FDG PET\/CT","volume":"16","author":"Hofman","year":"2016","journal-title":"Cancer Imaging"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108527_b0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lungcan.2013.04.012","article-title":"Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET\/CT: potential value in the clinic","volume":"81","author":"Li","year":"2013","journal-title":"Lung Cancer"},{"issue":"9315","key":"10.1016\/j.lungcan.2025.108527_b0240","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(02)08352-6","article-title":"Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial","volume":"359","author":"van Tinteren","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2025.108527_b0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lungcan.2018.01.021","article-title":"Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer","volume":"118","author":"Baine","year":"2018","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108527_b0250","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2018.01.050","article-title":"A retrospective long-term follow-up study of stereotactic body radiation therapy for non-small cell lung cancer from a single institution: incidence of late local recurrence","volume":"100","author":"Shintani","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.lungcan.2025.108527_b0255","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jtho.2018.06.007","article-title":"Histology, tumor volume, and radiation dose predict outcomes in NSCLC patients after stereotactic ablative radiotherapy","volume":"13","author":"Shiue","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108527_b0260","article-title":"Safety and efficacy of stereotactic ablative radiotherapy for ultra-central lung cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0265","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2016.09.036","article-title":"Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (>\/=5 Centimeter) non-small cell lung cancer","volume":"97","author":"Verma","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108527_b0270","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/0284186X.2020.1750693","article-title":"Prognostic factors of local control and disease free survival in centrally located non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"59","author":"Duijm","year":"2020","journal-title":"Acta Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108527_b0275","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.21037\/tlcr-23-180","article-title":"Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study","volume":"12","author":"Guo","year":"2023","journal-title":"Transl Lung Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108527_b0280","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2020.10.028","article-title":"The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer","volume":"155","author":"Amin","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2025.108527_b0285","first-page":"37","article-title":"Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer","volume":"5","author":"Holmes","year":"2017","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108527_b0290","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.prro.2018.09.001","article-title":"Defining optimal comorbidity measures for patients with early-stage non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"9","author":"DeWees","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2025.108527_b0295","unstructured":"A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY). (STRICTSTARLUNG) https:\/\/ichgcp.net\/clinical-trials-registry\/NCT05354596."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:55:27Z","timestamp":1778536527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225004192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":67,"alternative-id":["S0169500225004192"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108527","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) \u2212 A subgroup analysis of the expanded HILUS study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108527"}}